This content is machine translated Application for approval Alzheimer’s drug to be submitted for approval After consultation with the U.S. Food and Drug Administration (FDA), the manufacturer Biogen plans to submit aducanumab for approval. The Phase 3 EMERGE study met its primary endpoint and demonstrated…
View Post 5 min This content is machine translated AAIC in Chicago Is amyloid still tenable as a therapeutic target? Much research has been done in the field of Alzheimer’s disease. Yet, to date, no drug candidate has convincingly translated the battle against beta-amyloid into cognitive benefits across all study…
